Year |
Citation |
Score |
2016 |
Avery BA, Vuppala PK, Jamalapuram S, Sharma A, Mesangeau C, Chin FT, McCurdy CR. Quantification of Highly Selective Sigma-1 Receptor Antagonist CM304 using Liquid Chromatography Tandem Mass Spectrometry and its application to a Pre-clinical Pharmacokinetic Study. Drug Testing and Analysis. PMID 28039926 DOI: 10.1002/Dta.2156 |
0.744 |
|
2016 |
Patel YT, Jacus MO, Davis AD, Boulos N, Turner DC, Vuppala PK, Freeman BB, Gilbertson RJ, Stewart CF. Simvastatin Hydroxy Acid Fails to Attain Sufficient CNS Tumor Exposure to Achieve Cytotoxic Effect: Result of a Preclinical Cerebral Microdialysis Study. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 26802130 DOI: 10.1124/Dmd.115.068445 |
0.342 |
|
2015 |
Patel YT, Jacus MO, Boulos N, Dapper JD, Davis AD, Vuppala PK, Freeman BB, Mohankumar KM, Throm SL, Gilbertson RJ, Stewart CF. Preclinical examination of clofarabine in pediatric ependymoma: intratumoral concentrations insufficient to warrant further study. Cancer Chemotherapy and Pharmacology. 75: 897-906. PMID 25724157 DOI: 10.1007/S00280-015-2713-Z |
0.384 |
|
2014 |
James ML, Shen B, Nielsen CH, Behera D, Buckmaster CL, Mesangeau C, Zavaleta C, Vuppala PK, Jamalapuram S, Avery BA, Lyons DM, McCurdy CR, Biswal S, Gambhir SS, Chin FT. Evaluation of σ-1 receptor radioligand 18F-FTC-146 in rats and squirrel monkeys using PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 147-53. PMID 24337599 DOI: 10.2967/Jnumed.113.120261 |
0.662 |
|
2014 |
Patel YT, Jacus MO, Davis AD, Vuppala P, Dapper JD, Freeman BB, Boulos N, Throm SL, Gilbertson RJ, Stewart CF. Abstract 4645: Clofarabine, a potent anticancer compound with limited penetration in an orthotopic murine model of ependymoma Cancer Research. 74: 4645-4645. DOI: 10.1158/1538-7445.Am2014-4645 |
0.441 |
|
2013 |
Vuppala PK, Jamalapuram S, Furr EB, McCurdy CR, Avery BA. Development and validation of a UPLC-MS/MS method for the determination of 7-hydroxymitragynine, a μ-opioid agonist, in rat plasma and its application to a pharmacokinetic study. Biomedical Chromatography : Bmc. 27: 1726-32. PMID 23893615 DOI: 10.1002/Bmc.2986 |
0.754 |
|
2013 |
Jamalapuram S, Vuppala PK, Abdelazeem AH, McCurdy CR, Avery BA. Ultra-performance liquid chromatography tandem mass spectrometry method for the determination of AZ66, a sigma receptor ligand, in rat plasma and its application to in vivo pharmacokinetics. Biomedical Chromatography : Bmc. 27: 1034-40. PMID 23558564 DOI: 10.1002/Bmc.2901 |
0.751 |
|
2013 |
Turner DC, Freeman BB, Jacus MO, Morfouace M, Throm SL, Vuppala PK, Roussel M, Gajjar A, Stewart CF. Abstract 2749: Gemcitabine (GEM), a drug with clinical activity against pediatric solid tumors, demonstrates satisfactory CNS penetration in a preclinical murine medulloblastoma (MB) model. Cancer Research. 73: 2749-2749. DOI: 10.1158/1538-7445.Am2013-2749 |
0.441 |
|
2012 |
James ML, Shen B, Zavaleta CL, Nielsen CH, Mesangeau C, Vuppala PK, Chan C, Avery BA, Fishback JA, Matsumoto RR, Gambhir SS, McCurdy CR, Chin FT. New positron emission tomography (PET) radioligand for imaging σ-1 receptors in living subjects. Journal of Medicinal Chemistry. 55: 8272-82. PMID 22853801 DOI: 10.1021/Jm300371C |
0.642 |
|
2012 |
Jamalapuram S, Vuppala PK, Mesangeau C, McCurdy CR, Avery BA. Determination of a highly selective mixed-affinity sigma receptor ligand, in rat plasma by ultra performance liquid chromatography mass spectrometry and its application to a pharmacokinetic study. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 891: 1-6. PMID 22406103 DOI: 10.1016/J.Jchromb.2011.12.013 |
0.754 |
|
2011 |
Vuppala PK, Boddu SP, Furr EB, McCurdy CR, Avery BA. Simple, sensitive, high-throughput method for the quantification of mitragynine in rat plasma using UPLC-MS and its application to an intravenous pharmacokinetic study Chromatographia. 74: 703-710. DOI: 10.1007/S10337-011-2128-X |
0.821 |
|
Show low-probability matches. |